Virtu Financial LLC Infla Rx N.V. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	SELL	$1.25 - $2.75 $2,298 - $5,057	-1,839 Reduced 7.95%	21,299 $35,000
Q3 2023 Nov 14, 2023	BUY	$2.66 - $4.33 $61,547 - $100,187	23,138 New	23,138 $69,000
Q2 2022 Aug 09, 2022	SELL	$0.78 - $1.9 $22,549 - $54,927	-28,909 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$1.83 - $4.48 $52,903 - $129,512	28,909 New	28,909 $53,000
Q4 2021 Feb 17, 2022	SELL	$2.35 - $5.58 $61,137 - $145,169	-26,016 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.25 - $3.03 $58,536 - $78,828	26,016 New	26,016 $67,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.